Combination of at least two compounds selected from an AT1-Receptor antagonist or an ACE inhibitor or a HMGCO-A reductase inhibitor group

Details for Australian Patent Application No. 2005209657 (hide)

Owner Novartis AG

Inventors Graves, Kurt C.; De Gasparo, Marc

Agent Davies Collison Cave

Pub. Number AU-A-2005209657

Parent 2001258323

Filing date 9 September 2005

Wipo publication date 29 September 2005

International Classifications

A61K 031/00

Event Publications

29 September 2005 Application Open to Public Inspection

  Published as AU-A-2005209657

29 September 2005 Complete Application Filed

6 November 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005209658-Aromatic and heterocyclic derivatives of phytosterols and/or phytostanols for use in treating or preventing cardiovascular disease

2005209656-Manufactured seed having a live end seal coating